(1)
Bimekizumab Impact on Pain in Moderate to Severe Hidradenitis Suppurativa: Week 16 Results from BE HEARD I & II. J of Skin 2024, 8 (1), s350. https://doi.org/10.25251/skin.8.supp.350.